KPV: Discovery & Research History
KPV (α-MSH(11–13) Tripeptide Fragment) — how it was originally discovered, and what it has been studied for since.
How KPV Was Discovered
KPV's research history begins with alpha-MSH (alpha-melanocyte-stimulating hormone), a molecule long known for its role in skin pigmentation. Starting in the 1980s, researchers including Anna Catania and James Lipton at Weill Cornell Medical College ran a systematic series of studies showing that alpha-MSH could also reduce fever, suppress inflammatory responses, and modulate immune cell activity — effects that had nothing to do with pigmentation at all.
That raised an obvious question: which part of the molecule was actually responsible for the anti-inflammatory activity? By testing progressively smaller fragments of alpha-MSH, researchers found that its C-terminal tripeptide — lysine-proline-valine, or KPV — retained most or all of the parent hormone's anti-inflammatory potency on its own. Hiltz and Lipton's 1989 publication was the key demonstration of this, showing that KPV retained significant anti-inflammatory activity in vitro despite lacking the core sequence alpha-MSH needs to bind melanocortin receptors in the first place. That's the mechanistic detail that matters most for KPV's research use today: because it doesn't engage melanocortin receptors or raise intracellular cAMP the way alpha-MSH does, it can be studied for anti-inflammatory activity without the pigmentary or broader hormonal effects that come with the full-length hormone.
What KPV Has Been Studied For
Roughly two dozen published studies examined KPV specifically between 2001 and 2025, most focused on its ability to interrupt inflammatory signaling in tissues like the gut, lungs, and skin — building directly on the Weill Cornell group's original anti-inflammatory findings.
- Anti-inflammatory mechanism research
- Gut inflammation models
- Cytokine signaling research
KPV discovery & history questions
Does KPV's research history mean it's approved for a particular use?
No. This page describes how KPV was originally discovered and what it has been studied for since — it is historical and educational context, not a claim about current regulatory approval, safety, or legal status anywhere. KYIN Peptides sells KPV strictly for laboratory research use.
What has KPV been studied for in research?
KPV is most commonly studied in anti-inflammatory mechanism research, gut inflammation models, and cytokine signaling research.
Looking for KPV specs and pricing?
View purity, available sizes, and pricing on the product page.